Replies to post #632 on CardioVascular BioTherapeutics (fka CVBT)

[walhall]

Wow, this is great news to hear that CVBT has raised new equity at $3/share!!! (Which gives CVBT a valuation of about $1 billion - there really IS a Santa Claus after all.)

Someone deep inside CVBT told me that the investor was the North Korean Sovereign Wealth Fund.